Literature DB >> 17112407

Intrathecal administration of Cav3.2 and Cav3.3 antisense oligonucleotide reverses tactile allodynia and thermal hyperalgesia in rats following chronic compression of dorsal root of ganglion.

Xian-jie Wen1, Zhang-jun Li, Zhi-xin Chen, Zhi-yuan Fang, Chen-xiang Yang, Heng Li, Yin-ming Zeng.   

Abstract

AIM: The present study aimed to elucidate the role of T-subtype calcium channels (Cav3.1, Cav3.2, and Cav3.3) in the pathogenesis of neuropathic pain at spinal level.
METHODS: The chronic compression of the dorsal root ganglion (CCD) rat model was adopted. The antisense oligonucleotide of Cav3.1, Cav3.2, and Cav3.3 or normal saline (NS) were intrathecally administered twice per day from the first day to the fourth day after operation. Paw mechanical withdrawal threshold and paw thermal withdrawal latency were measured to evaluate the tactile allodynia and thermal hyperalgesia, respectively.
RESULTS: CCD rats developed reliable tactile allodynia and thermal hyperalgesia after operation. Intrathecal administration of antisense oligonucleotide of Cav3.2 and Cav3.3 significantly relieved tactile allodynia and thermal hyperalgesia in CCD rats, but not Cav3.1.
CONCLUSION: Cav3.2 and Cav3.3 subtype calcium channels in the spinal cord may play an important role in the pathogenesis of neuropathic pain, which may contribute to the management of the neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17112407     DOI: 10.1111/j.1745-7254.2006.00461.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  23 in total

Review 1.  T-type voltage-gated calcium channels as targets for the development of novel pain therapies.

Authors:  Slobodan M Todorovic; Vesna Jevtovic-Todorovic
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

2.  Surfen is a broad-spectrum calcium channel inhibitor with analgesic properties in mouse models of acute and chronic inflammatory pain.

Authors:  Paula Rivas-Ramirez; Vinicius M Gadotti; Gerald W Zamponi; Norbert Weiss
Journal:  Pflugers Arch       Date:  2017-06-30       Impact factor: 3.657

3.  Characterisation of rebound depolarisation in mice deep dorsal horn neurons in vitro.

Authors:  Ivan Rivera-Arconada; Jose A Lopez-Garcia
Journal:  Pflugers Arch       Date:  2014-10-09       Impact factor: 3.657

Review 4.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

5.  Contribution of T-Type Calcium Channels to Spinal Cord Injury-Induced Hyperexcitability of Nociceptors.

Authors:  Justas Lauzadis; Huilin Liu; Yong Lu; Mario J Rebecchi; Martin Kaczocha; Michelino Puopolo
Journal:  J Neurosci       Date:  2020-08-24       Impact factor: 6.167

6.  Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels.

Authors:  Vinicius M Gadotti; Chris Bladen; Fang Xiong Zhang; Lina Chen; Miyase Gözde Gündüz; Rahime Şimşek; Cihat Şafak; Gerald W Zamponi
Journal:  Pflugers Arch       Date:  2015-08-19       Impact factor: 3.657

7.  Proteomic analysis of differential proteins related to the neuropathic pain and neuroprotection in the dorsal root ganglion following its chronic compression in rats.

Authors:  Yang Zhang; Yong-Hui Wang; Xu-Hua Zhang; Hong-You Ge; Lars Arendt-Nielsen; Jian-Min Shao; Shou-Wei Yue
Journal:  Exp Brain Res       Date:  2008-05-21       Impact factor: 1.972

8.  Two heterozygous Cav3.2 channel mutations in a pediatric chronic pain patient: recording condition-dependent biophysical effects.

Authors:  Ivana A Souza; Maria A Gandini; Miranda M Wan; Gerald W Zamponi
Journal:  Pflugers Arch       Date:  2015-12-26       Impact factor: 3.657

Review 9.  Abnormal calcium homeostasis in peripheral neuropathies.

Authors:  Paul Fernyhough; Nigel A Calcutt
Journal:  Cell Calcium       Date:  2009-12-24       Impact factor: 6.817

Review 10.  Voltage-dependent CaV3.2 and CaV2.2 channels in nociceptive pathways.

Authors:  Lucia Hoppanova; Lubica Lacinova
Journal:  Pflugers Arch       Date:  2022-01-18       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.